2006: A Stroke Odyssey

References

1. ↵
   Smith W, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–40

   Abstract/FREE Full Text
2. ↵
   Haley EC, Levy DE, Brott TG, et al. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset. Stroke 1992;23:641–45

   Abstract/FREE Full Text
3. ↵
   Brott TG, Haley EC, Levy DE, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992;23:632–40

   Abstract/FREE Full Text
4. ↵
   Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultra-early thrombolytic therapy. AJNR Am J Neuroradiol 1996;17:79–85

   Abstract
5. ↵
   Zeumer H, Freitag HJ, Zanella F, et al. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 1993;35:159–62

   CrossRefPubMedWeb of Science
6. ↵
   Tomsick TA. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol 1994;15:16–18

   FREE Full Text
7. ↵
   Lewandowski C, Frankel M, Tomsick T, et al, and the EMS Bridging Trial Investigators. Combined intravenous and intra-arterial r-tPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598–605

   Abstract/FREE Full Text
8. ↵
   The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–87

   CrossRefPubMedWeb of Science
9. ↵
   Furlan A, Higashida R, Weschler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II Study—a randomized controlled trial, Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
10. ↵
    Flaherty ML, Woo D, Kissells B, et al. Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005;64:386–88

    Abstract/FREE Full Text
11. ↵
    The IMS investigators. Combined intravenous and intraarterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke 2004;35:904–12

    Abstract/FREE Full Text
12. ↵
    Mahon BR, Nesbit GM, Barnwell SL, et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of stroke. AJNR Am J Neuroradiol 2003;24:534–38

    Abstract/FREE Full Text
13. ↵
    IMS II investigators. Preliminary results of IMS II Trial [abstract]. Stroke 2006;37:708
14. ↵
    Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330–35

    Abstract/FREE Full Text
15. ↵
    Khatri P, Broderick JP, Khoury J, et al. Microcatheter contrast injections during intra-arterial thrombolysis increase intracranial hemorrhage risk [abstract]. Stroke 2006;37:622
16. ↵
    Lees KR, Zivin JA, Ashwood T, et al. NXY-059 for acute ischemic stroke. N Engl J Med 2006;354:588–600

    CrossRefPubMedWeb of Science